Presa M, Soria A, Oyagüez I, Espinosa E, Echave M, Berrocal A, Manzano JL, Suarez J, Polanco C
Nivolumab-adjuvant therapy for resected stage III-IV melanoma: a cost-effectiveness analysis for Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Soria A, Presa M, Espinosa E, Oyagüez I, Berrocal A, Echave M, Manzano JL, Suárez J, Polanco C
Análisis coste-efectividad de nivolumab en el tratamiento adyuvante del melanoma avanzado completamente resecado
Congreso de la Sociedad Española de Oncología Médica. Pamplona. 22-25 oct 2019
Ruiz-Moreno JM, de Andrés-Nogales F, Oyagüez I, Ruiz-Medrano J
Cost-consequence Analysis of Extended Loading Dose from 3 to 6 months of Anti VEGF Treatment In Diabetic Macular Edema Patients
Euretina Congress. Paris (France). 5-8 sep 2019
Oyagüez I, Suárez C, López-Sendón JL, González-Juanatey JR, de Andrés-Nogales F, Suarez J, Polanco C, Soto J
Cost-effectiveness analysis of apixaban versus edoxaban in atrial fibrillation patients for stroke prevention
Pharmacoecon Open. 2020;4(3):485-497
Presa M, Pérez-Ruiz F, Oyagüez I
2nd line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
Clin. Rheumatol 2019. doi: 10.1007/s10067-019-04739-3
Capel M, Ciudin A, Mareque M, Rodríguez-Rincón RM, Simón S, Oyagüez I
Cost-effectiveness analysis of exenatide versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus
PharmacoEconomics – Open 2020; 4, 277–286
Presa M, Pérez-Ruiz F, Oyagüez I
2nd line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
European Congress of Rheumatology 2019 (EULAR). Madrid. 12-15 jun 2019
Peral C, Balsa A, Pablos JL, Navarro F, Martínez-Sesmero JM, Montoro M, Gómez S, Valderrama M, de Andrés-Nogales F, Casado MA, Oyagüez I
Efficiency of treatment sequences containing tofacitinib for rheumatoid arthritis in Spain
European Congress of Rheumatology 2019 (EULAR). Madrid. 12-15 jun 2019
García-Herola A, Domínguez-Hernández R, Casado MA